Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands

被引:95
|
作者
Arenzana-Seisdedos, Fernando
Parmentier, Marc
机构
[1] Inst Pasteur, INSERM, Dept Virol, Unite Pathogenie Virale Mol, F-75724 Paris, France
[2] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium
关键词
chemokine receptors; HIV co-receptors; genetic variants; CCR5; CCR2;
D O I
10.1016/j.smim.2006.07.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Susceptibility to HIV infection and AIDS progression is variable among individuals and populations, and in part genetically determined. Genetic variants of genes encoding HIV co-receptors and their chemokine ligands have been described, and some of these variants were associated with resistance to HIV infection and/or disease progression. We review here the reported data regarding the variants of the CCR5, CCR2, MCRI, MIP-1 alpha/CCL3, MIP-1 beta CCL4, RANTES/CCL5 and SDF-1/CXCL12 genes. The Delta 32 deletion mutant of CCR5, resulting in a non-functional receptor not reaching the cell surface, is unambiguously associated with strong, although incomplete, resistance to HIV infection for homozygotes, and retarded progression for heterozygotes. Specific haplotypes encompassing the CCR5 and CCR2 loci, and the copy number of the CCL3L1 gene, have also been convincingly correlated with delayed progression. For other gene variants, involving CXCL12/SDF-1 and CX3CR1, conclusive evidence for their relevance in the frame of HIV susceptibility is still lacking. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:387 / 403
页数:17
相关论文
共 50 条
  • [1] Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands
    Simmons, G
    Reeves, JD
    Hibbitts, S
    Stine, JT
    Gray, PW
    Proudfoot, AEI
    Clapham, PR
    IMMUNOLOGICAL REVIEWS, 2000, 177 : 112 - 126
  • [2] Functional Role of the RET Dependence Receptor, GFRa Co-Receptors and Ligands in the Pituitary
    Garcia-Lavandeira, Montserrat
    Diaz-Rodriguez, Esther
    Garcia-Rendueles, Maria E. R.
    Rodrigues, Joana S.
    Perez-Romero, Sihara
    Bravo, Susana B.
    Alvarez, Clara V.
    PITUITARY TODAY II: NEW MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, 2010, 38 : 127 - 138
  • [3] Controlling HIV infection HIV co-receptor gets the finger
    Kelleher, Anthony D.
    Purcell, Damian F.
    IMMUNOLOGY AND CELL BIOLOGY, 2008, 86 (08): : 641 - 642
  • [4] A chemokine trap for HIV co-receptors
    Paolo Lusso
    Nature Medicine, 1997, 3 : 1074 - 1075
  • [5] A chemokine trap for HIV co-receptors
    Lusso, P
    NATURE MEDICINE, 1997, 3 (10) : 1074 - 1075
  • [6] HIV-1 — co-receptors binding
    Shibo Jiang
    Nature Medicine, 1997, 3 : 367 - 368
  • [7] Co-receptors for HIV-1 entry
    Moore, JP
    CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (04) : 551 - 562
  • [8] HIV co-receptors as targets for antiviral therapy
    Schols, D
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) : 883 - 893
  • [9] HIV-1 - Co-receptors binding
    Jiang, SB
    NATURE MEDICINE, 1997, 3 (04) : 367 - 368
  • [10] Expression and utilization of co-receptors in HIV and simian immunodeficiency virus infection of megakaryocytes
    Park, IW
    Wang, JF
    Groopman, JE
    AIDS, 1999, 13 (15) : 2023 - 2032